Cellectis (CLLS) is scheduled to report Q3 earnings on November 6, 2026. Analysts estimate EPS of $-0.2 and quarterly revenue of $13.15M.
In the most recent quarter (Q2), Cellectis reported EPS of $-0.19, beating estimates of $-0.26 by 0.27%. Revenue came in at $6.9M, missing the estimate of $9.38M by 0.26%.
Cellectis has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Cellectis has averaged an EPS surprise of 0.81% and a revenue surprise of 1.03%.
Earnings Date
Nov 6
EPS Estimate
$-0.200
Quarterly Revenue Estimate
$13.15M
Annual Revenue
$56.58M
as of Jun 30
Analyze the earnings history of Cellectis using advanced sorting and filters.
The chart below shows Cellectis's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Cellectis's reported revenue compared to analyst estimates over recent quarters.
Cellectis (CLLS) is scheduled to report earnings on November 6, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
The Actual EPS was $-0.19, which beat the estimate of $-0.26.
The Actual Revenue was $6.9M, which missed the estimate of $9.38M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.19 | $-0.26 | 26.9 % |
| Q1 | May 11, 2026 | $-0.16 | $-0.26 | 38.5 % |
| Q4 | Mar 19, 2026 | $-0.24 | $-0.10 | -140.0 % |
| Q3 | Nov 7, 2025 | $0.02 | $-0.10 | 120.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $6.90M | $9.38M | -26.4 % |
| Q1 | May 11, 2026 | $7.55M | $9.37M | -19.5 % |
| Q4 | Mar 19, 2026 | $12.21M | $10.74M | 13.7 % |
| Q3 | Nov 7, 2025 | $37.16M | $8.19M | 354.0 % |